<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35889971</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-0817</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>7</Issue><PubDate><Year>2022</Year><Month>Jun</Month><Day>25</Day></PubDate></JournalIssue><Title>Pathogens (Basel, Switzerland)</Title><ISOAbbreviation>Pathogens</ISOAbbreviation></Journal><ArticleTitle>Associated-Onset Symptoms and Post-COVID-19 Symptoms in Hospitalized COVID-19 Survivors Infected with Wuhan, Alpha or Delta SARS-CoV-2 Variant.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">725</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/pathogens11070725</ELocationID><Abstract><AbstractText>This study compared associated-symptoms at the acute phase of infection and post-COVID-19 symptoms between individuals hospitalized with the Wuhan, Alpha or Delta SARS-CoV-2 variant. Non-vaccinated individuals hospitalized because of SARS-CoV-2 infection in one hospital during three different waves of the pandemic (Wuhan, Alpha or Delta) were scheduled for a telephone interview. The presence of post-COVID-19 symptoms was systematically assessed. Hospitalization and clinical data were collected from medical records. A total of 201 patients infected with the Wuhan variant, 211 with the Alpha variant and 202 with Delta variant were assessed six months after hospitalization. Patients infected with the Wuhan variant had a greater number of symptoms at hospital admission (higher prevalence of fever, dyspnea or gastrointestinal problems) than those infected with Alpha or Delta variant (p &lt; 0.01). A greater proportion of patients infected with the Delta variant reported headache, anosmia or ageusia as onset symptoms (p &lt; 0.01). The mean number of post-COVID-19 symptoms was higher (p &lt; 0.001) in individuals infected with the Wuhan variant (mean: 2.7 &#xb1; 1.3) than in those infected with the Alpha (mean: 1.8 &#xb1; 1.1) or Delta (mean: 2.1 &#xb1; 1.5) variant. Post-COVID-19 dyspnea was more prevalent (p &lt; 0.001) in people infected with the Wuhan variant, whereas hair loss was higher in those infected with the Delta variant (p = 0.002). No differences in post-COVID-19 fatigue by SARS-CoV-2 variant were found (p = 0.594). Differences in COVID-19 associated onset symptoms and post-COVID-19 dyspnea were observed depending on the SARS-CoV-2 variant. The presence of fatigue was a common post-COVID-19 symptom to all SARS-CoV-2 variants.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-de-Las-Pe&#xf1;as</LastName><ForeName>C&#xe9;sar</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3772-9690</Identifier><AffiliationInfo><Affiliation>Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Universidad Rey Juan Carlos (URJC), 28922 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CNAP, Center for Sensory-Motor Interaction (SMI), Department of Health Science and Technology, Faculty of Medicine, Aalborg University, 9220 Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cancela-Cilleruelo</LastName><ForeName>Ignacio</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Universidad Rey Juan Carlos (URJC), 28922 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez-Jim&#xe9;nez</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Universidad Rey Juan Carlos (URJC), 28922 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;mez-Mayordomo</LastName><ForeName>Victor</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-9343-8439</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Hospital Cl&#xed;nico San Carlos, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pellicer-Valero</LastName><ForeName>Oscar J</ForeName><Initials>OJ</Initials><Identifier Source="ORCID">0000-0002-0104-1029</Identifier><AffiliationInfo><Affiliation>Intelligent Data Analysis Laboratory, Department of Electronic Engineering, ETSE (Engineering School), Universitat de Val&#xe8;ncia (UV), 46010 Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;n-Guerrero</LastName><ForeName>Jos&#xe9; D</ForeName><Initials>JD</Initials><Identifier Source="ORCID">0000-0001-9378-0285</Identifier><AffiliationInfo><Affiliation>Intelligent Data Analysis Laboratory, Department of Electronic Engineering, ETSE (Engineering School), Universitat de Val&#xe8;ncia (UV), 46010 Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern&#xe1;ndez-Barrera</LastName><ForeName>Valent&#xed;n</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Public Health, Universidad Rey Juan Carlos (URJC), 28922 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arendt-Nielsen</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>CNAP, Center for Sensory-Motor Interaction (SMI), Department of Health Science and Technology, Faculty of Medicine, Aalborg University, 9220 Aalborg, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Gastroenterology, Aalborg University Hospital, 9100 Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres-Macho</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Hospital Universitario Infanta Leonor-Virgen de la Torre, 28031 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, School of Medicine, Universidad Complutense de Madrid, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>LONG COVID EXP CM</GrantID><Agency>Comunidad de Madrid</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Pathogens</MedlineTA><NlmUniqueID>101596317</NlmUniqueID><ISSNLinking>2076-0817</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Wuhan</Keyword><Keyword MajorTopicYN="N">alpha</Keyword><Keyword MajorTopicYN="N">delta</Keyword><Keyword MajorTopicYN="N">post-COVID-19</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword><Keyword MajorTopicYN="N">variant</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>27</Day><Hour>1</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35889971</ArticleId><ArticleId IdType="pmc">PMC9320021</ArticleId><ArticleId IdType="doi">10.3390/pathogens11070725</ArticleId><ArticleId IdType="pii">pathogens11070725</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Parra-Lucares A., Segura P., Rojas V., Pumarino C., Saint-Pierre G., Toro L. Emergence of SARS-CoV-2 variants in the world: How could this happen? Life. 2022;12:194. doi: 10.3390/life12020194.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12020194</ArticleId><ArticleId IdType="pmc">PMC8879166</ArticleId><ArticleId IdType="pubmed">35207482</ArticleId></ArticleIdList></Reference><Reference><Citation>Thye A.Y., Law J.W., Pusparajah P., Letchumanan V., Chan K.G., Lee L.H. Emerging SARS-CoV-2 Variants of Concern (VOCs): An Impending Global Crisis. Biomedicines. 2021;9:1303. doi: 10.3390/biomedicines9101303.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9101303</ArticleId><ArticleId IdType="pmc">PMC8533361</ArticleId><ArticleId IdType="pubmed">34680420</ArticleId></ArticleIdList></Reference><Reference><Citation>Teyssou E., Delagr&#xe8;verie H., Visseaux B., Lambert-Niclot S., Brichler S., Ferre V., Marot S., Jary A., Todesco E., Schnuriger A., et al. The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients. J. Infect. 2021;83:e1&#x2013;e3. doi: 10.1016/j.jinf.2021.08.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.08.027</ArticleId><ArticleId IdType="pmc">PMC8375250</ArticleId><ArticleId IdType="pubmed">34419559</ArticleId></ArticleIdList></Reference><Reference><Citation>Karim S.S.A., Karim Q.A. Omicron SARS-CoV-2 variant: A new chapter in the COVID-19 pandemic. Lancet. 2021;398:2126&#x2013;2128. doi: 10.1016/S0140-6736(21)02758-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02758-6</ArticleId><ArticleId IdType="pmc">PMC8640673</ArticleId><ArticleId IdType="pubmed">34871545</ArticleId></ArticleIdList></Reference><Reference><Citation>Tani-Sassa C., Iwasaki Y., Ichimura N., Nagano K., Takatsuki Y., Yuasa S., Takahashi Y., Nakajima J., Sonobe K., Nukui Y., et al. Viral loads and profile of the patients infected with SARS-CoV-2 Delta, Alpha, or R.1 variants in Tokyo. J. Med. Virol. 2022;94:1707&#x2013;1710. doi: 10.1002/jmv.27479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27479</ArticleId><ArticleId IdType="pmc">PMC9015476</ArticleId><ArticleId IdType="pubmed">34825717</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman S., Montero M.T.V., Rowe K., Kirton R., Kunik F., Jr. Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: A review of current evidence. Expert Rev. Clin. Pharmacol. 2021;14:601&#x2013;621. doi: 10.1080/17512433.2021.1902303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17512433.2021.1902303</ArticleId><ArticleId IdType="pmc">PMC8095162</ArticleId><ArticleId IdType="pubmed">33705239</ArticleId></ArticleIdList></Reference><Reference><Citation>Struyf T., Deeks J.J., Dinnes J., Takwoingi Y., Davenport C., Leeflang M.M., Spijker R., Hooft L., Emperador D., Dittrich S., et al. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease. Cochrane Database Syst. Rev. 2020;7:CD013665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7386785</ArticleId><ArticleId IdType="pubmed">32633856</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J., Ji P., Pang J., Zhong Z., Li H., He C., Zhang J., Zhao C. Clinical characteristics of 3062 COVID-19 patients: A meta-analysis. J. Med. Virol. 2020;92:1902&#x2013;1914. doi: 10.1002/jmv.25884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25884</ArticleId><ArticleId IdType="pmc">PMC7262119</ArticleId><ArticleId IdType="pubmed">32293716</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoang V.T., Colson P., Levasseur A., Delerce J., Lagier J.C., Parola P., Million M., Fournier P.E., Raoult D., Gautret P. Clinical outcomes in patients infected with different SARS-CoV-2 variants at one hospital during three phases of the COVID-19 epidemic in Marseille, France. Infect. Genet. Evol. 2021;95:105092. doi: 10.1016/j.meegid.2021.105092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2021.105092</ArticleId><ArticleId IdType="pmc">PMC8462069</ArticleId><ArticleId IdType="pubmed">34571275</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S., Lim S.Y., Kim J.Y., Park H., Lim J.S., Bae S., Kim J., Jung J., Kim M.J., Chong Y.P., et al. Clinical and virological characteristics of SARS-CoV-2 B.1.617.2 (Delta) variant: A prospective cohort study. Clin. Infect. Dis. 2022;1:ciac239. doi: 10.1093/cid/ciac239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac239</ArticleId><ArticleId IdType="pmc">PMC9047158</ArticleId><ArticleId IdType="pubmed">35362530</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C. Long COVID: Current definition. Infection. 2022;50:285&#x2013;286. doi: 10.1007/s15010-021-01696-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01696-5</ArticleId><ArticleId IdType="pmc">PMC8438555</ArticleId><ArticleId IdType="pubmed">34519974</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V., WHO Clinical Case Definition Working Group on Post-COVID-19 Condition A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Palacios-Ce&#xf1;a D., G&#xf3;mez-Mayordomo V., Florencio L.L., Cuadrado M.L., Plaza-Manzano G., Navarro-Santana M. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. Eur. J. Int. Med. 2021;92:55&#x2013;70. doi: 10.1016/j.ejim.2021.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q., Zheng B., Daines L., Sheikh A. Long-term sequelae of COVID-19: A systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens. 2022;11:269. doi: 10.3390/pathogens11020269.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Amdal C.D., Pe M., Falk R.S., Piccinin C., Bottomley A., Arraras J.I., Darlington A.S., Hofs&#xf8; K., Holzner B., J&#xf8;rgensen N.M.H., et al. Health-related quality of life issues, including symptoms, in patients with active COVID-19 or post COVID-19; a systematic literature review. Qual. Life Res. 2021;30:3367&#x2013;3381. doi: 10.1007/s11136-021-02908-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-021-02908-z</ArticleId><ArticleId IdType="pmc">PMC8214069</ArticleId><ArticleId IdType="pubmed">34146226</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward H., Flower B., Garcia P.J., Ong S.W.X., Altmann D.M., Delaney B., Smith N., Elliott P., Cooke G. Global surveillance, research, and collaboration needed to improve understanding and management of long COVID. Lancet. 2021;398:2057&#x2013;2059. doi: 10.1016/S0140-6736(21)02444-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02444-2</ArticleId><ArticleId IdType="pmc">PMC8580495</ArticleId><ArticleId IdType="pubmed">34774190</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinicci M., Nkurunziza I., Vellere I. SARS-CoV-2 variants may induce different long COVID phenotypes; Proceedings of the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID); Lisbon, Portugal. 23&#x2013;26 April 2022; Abstract 000193.</Citation></Reference><Reference><Citation>Mattiuzzi C., Henry B.M., Lippi G. Is diffusion of SARS-CoV-2 variants of concern associated with different symptoms? J. Infect. 2022;84:94&#x2013;118. doi: 10.1016/j.jinf.2021.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.07.008</ArticleId><ArticleId IdType="pmc">PMC8280603</ArticleId><ArticleId IdType="pubmed">34274361</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahra S.A., Iddawela S., Pillai K., Choudhury R.Y., Harky A. Can symptoms of anosmia and dysgeusia be diagnostic for COVID-19? Brain Behav. 2020;10:e01839. doi: 10.1002/brb3.1839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.1839</ArticleId><ArticleId IdType="pmc">PMC7667367</ArticleId><ArticleId IdType="pubmed">32935915</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi G., Nocini R., Henry B.M. Analysis of online search trends suggests that SARS-CoV-2 Omicron (B.1.1.529) variant causes different symptoms. J. Infect. 2022;84:E76&#x2013;E77. doi: 10.1016/j.jinf.2022.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.02.011</ArticleId><ArticleId IdType="pmc">PMC8851877</ArticleId><ArticleId IdType="pubmed">35183609</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (NCIRD)  [(accessed on 23 April 2022)]; Available online:  https://www.cdc.gov/flu/symptoms/flu-vs-covid19.htm.</Citation></Reference><Reference><Citation>Huang Y., Lu Y., Huang Y.M., Wang M., Ling W., Sui Y., Zhao H.L. Obesity in patients with COVID-19: A systematic review and meta-analysis. Metabolism. 2020;113:154378. doi: 10.1016/j.metabol.2020.154378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2020.154378</ArticleId><ArticleId IdType="pmc">PMC7521361</ArticleId><ArticleId IdType="pubmed">33002478</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay A. A paradigm for post-COVID-19 fatigue syndrome analogous to ME/CFS. Front. Neurol. 2021;12:701419. doi: 10.3389/fneur.2021.701419.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.701419</ArticleId><ArticleId IdType="pmc">PMC8365156</ArticleId><ArticleId IdType="pubmed">34408721</ArticleId></ArticleIdList></Reference><Reference><Citation>Haffke M., Freitag H., Rudolf G., Seifert M., Doehner W., Scherbakov N., Hanitsch L., Wittke K., Bauer S., Konietschke F., et al. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS) J. Transl. Med. 2022;20:138. doi: 10.1186/s12967-022-03346-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03346-2</ArticleId><ArticleId IdType="pmc">PMC8938726</ArticleId><ArticleId IdType="pubmed">35317812</ArticleId></ArticleIdList></Reference><Reference><Citation>Menges D., Ballouz T., Anagnostopoulos A., Aschmann H.E., Domenghino A., Fehr J.S., Puhan M.A. Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study. PLoS ONE. 2021;16:e0254523. doi: 10.1371/journal.pone.0254523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254523</ArticleId><ArticleId IdType="pmc">PMC8274847</ArticleId><ArticleId IdType="pubmed">34252157</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Sullivan O. Long-term sequelae following previous coronavirus epidemics. Clin. Med. 2020;21:68&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850177</ArticleId><ArticleId IdType="pubmed">33144403</ArticleId></ArticleIdList></Reference><Reference><Citation>Boglione L., Meli G., Poletti F., Rostagno R., Moglia R., Cantone M., Esposito M., Scianguetta C., Domenicale B., Di F., et al. Pasquale Risk factors and incidence of long-COVID syndrome in hospitalized patients: Does remdesivir have a protective effect? QJM. 2022;114:865&#x2013;871. doi: 10.1093/qjmed/hcab297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcab297</ArticleId><ArticleId IdType="pmc">PMC8690187</ArticleId><ArticleId IdType="pubmed">34850210</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon M.A., Luginbuhl R.D., Parker R. Reduced incidence of long-COVID Symptoms related to administration of COVID-19 vaccines both before COVID-19 diagnosis and up to 12 weeks after. medRxiv. 2021 doi: 10.1101/2021.11.17.21263608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.11.17.21263608</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;ez-Fuertes F., Iglesias-Caballero M., Garc&#xed;a-P&#xe9;rez J., Monz&#xf3;n S., Jim&#xe9;nez P., Varona S., Cuesta I., Zaballos &#xc1;., Jim&#xe9;nez M., Checa L., et al. A founder effect led early SARS-CoV-2 transmission in Spain. J. Virol. 2021;95:e01583. doi: 10.1128/JVI.01583-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01583-20</ArticleId><ArticleId IdType="pmc">PMC7925114</ArticleId><ArticleId IdType="pubmed">33127745</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>